In Vitro Fertilization (IVF)
In vitro fertilization (IVF) is an assisted reproductive technology (ART) procedure in which eggs retrieved from the ovaries are fertilized with sperm in a laboratory and the resulting embryo is transferred to the uterus. The CDC National ART Surveillance System (NASS) 2022 Annual Report records a 49.7% live birth rate per egg retrieval for patients under 35 using their own eggs — across 582 US clinics performing approximately 847,000 annual ART cycles.
What Is IVF?
IVF is a 5-stage assisted reproductive technology (ART) procedure classified under Reproductive Endocrinology and Infertility (REI) and governed by ASRM Practice Guidelines and mandatory CDC NASS reporting under the Fertility Clinic Success Rate and Certification Act of 1992. The primary outcome metric is the live birth rate per egg retrieval, segmented by patient age across 5 brackets — under 35, 35–37, 38–40, 41–42, and over 42.
| Medical classification | Assisted Reproductive Technology (ART) |
| Medical subspecialty | Reproductive Endocrinology and Infertility (REI) |
| Governing standard | ASRM Practice Guidelines; CDC NASS mandatory reporting |
| Federal reporting law | Fertility Clinic Success Rate and Certification Act of 1992 |
| Primary success metric | Live birth rate per egg retrieval, segmented by patient age |
| CDC rate — under 35, own eggs | 49.7% per retrieval (NASS 2022) |
| Cycle types | Fresh embryo transfer; frozen embryo transfer (FET) |
| Stimulation protocol | Gonadotropin injections (FSH, LH) over 8–14 days |
| US clinics performing IVF | 582 (CDC NASS 2022) |
| Annual cycles (US) | ~847,000 (CDC NASS 2022) |
How Does IVF Work Step by Step?
IVF proceeds in 5 sequential clinical stages managed by a board-certified reproductive endocrinologist and an embryology laboratory. A complete fresh-transfer cycle spans 4–6 weeks from the first day of ovarian stimulation to the serum beta-hCG pregnancy test. A frozen embryo transfer (FET) cycle with PGT-A genetic testing spans 10–14 weeks.
How Does Ovarian Stimulation Work in IVF?
Injectable gonadotropins — FSH (follicle-stimulating hormone) and LH (luteinizing hormone) — are administered daily for 8–14 days to stimulate the ovaries to develop multiple follicles simultaneously, beyond the single follicle that matures in a natural menstrual cycle. Follicle growth and hormonal response are monitored every 1–3 days via serial transvaginal ultrasound and serum estradiol measurements. Stimulation ends when lead follicles reach 17–20 mm in diameter. A trigger injection — hCG (human chorionic gonadotropin) or a GnRH agonist — is administered exactly 34–36 hours before the scheduled egg retrieval.
What Happens During IVF Egg Retrieval?
Eggs are retrieved via transvaginal ultrasound-guided needle aspiration under intravenous sedation in a 20–30 minute outpatient procedure that requires no general anesthesia. A thin needle passes through the vaginal wall into each ovarian follicle to aspirate the follicular fluid containing the egg. An embryologist assesses each retrieved egg immediately for nuclear maturity — specifically MII (metaphase II) stage — in the adjacent embryology laboratory. Only MII-stage eggs are suitable for fertilization.
How Are Eggs Fertilized in IVF?
Mature MII eggs are fertilized using 1 of 2 methods: conventional insemination, in which a prepared sperm sample is placed with the egg in culture media, or ICSI (intracytoplasmic sperm injection), in which a single morphologically normal sperm is injected directly into each egg under a high-powered microscope. ICSI is indicated for severe male-factor infertility — including azoospermia and severe oligospermia — prior fertilization failure, or low total motile sperm count. Fertilization is confirmed by the appearance of 2 pronuclei 16–18 hours post-insemination.
How Are Embryos Cultured and Graded?
Fertilized embryos develop in sequential culture media for 5–6 days to the blastocyst stage, at which point embryologists assign each embryo a 3-part morphological grade: expansion score (1–6), inner cell mass quality (A–C), and trophectoderm quality (A–C). A grade-4AA blastocyst represents the highest-quality embryo suitable for transfer or biopsy. Preimplantation genetic testing for aneuploidy (PGT-A) is performed on a day-5 to day-7 trophectoderm biopsy for patients aged 38 and older, those with recurrent pregnancy loss, and chromosomal translocation carriers. Biopsied embryos are vitrified while awaiting genetic results, which take 7–14 days.
What Happens During IVF Embryo Transfer?
A single euploid or highest-grade blastocyst is transferred to the uterus via a soft catheter under transabdominal ultrasound guidance in a 10–15 minute office procedure that requires no anesthesia or sedation. For frozen embryo transfer (FET) cycles, the endometrial lining is prepared with estradiol and progesterone supplementation for 3–4 weeks prior to transfer. A serum beta-hCG pregnancy test is performed 9–11 days post-transfer to confirm implantation. Surplus high-quality blastocysts are vitrified for future FET cycles at an annual cryostorage cost of $500–$1,000.
What Is the IVF Success Rate in the United States?
How Does the CDC Measure IVF Success?
The CDC measures IVF success as the live birth rate per egg retrieval: the total number of retrievals that resulted in at least 1 live-born infant divided by all retrievals performed. The CDC NASS segments this rate by 5 patient age brackets — under 35, 35–37, 38–40, 41–42, and over 42 — and by egg type (own eggs vs. donor eggs) and embryo type (fresh transfer vs. frozen embryo transfer). The CDC NASS 2022 Annual Report covers 847,000 ART cycles across 582 US clinics that report outcomes annually under federal law.
What Is the IVF Live Birth Rate by Age?
| Under 35 — own eggs | 49.7% live birth rate per retrieval (highest cohort — CDC NASS 2022) |
| 35–37 — own eggs | 38.1% live birth rate per retrieval (CDC NASS 2022) |
| 38–40 — own eggs | 25.3% live birth rate per retrieval (CDC NASS 2022) |
| 41–42 — own eggs | 13.1% live birth rate per retrieval — donor egg IVF recommended |
| Over 42 — own eggs | 4.2% live birth rate per retrieval — donor eggs typically indicated |
| Donor egg — any recipient age | 60–70%+ live birth rate per transfer — outcome determined by donor's age, not recipient's |
Why Do IVF Success Rates Vary Between Clinics?
IVF success rates vary between the 582 CDC-indexed clinics because patient population mix, case complexity, stimulation protocols, and embryology laboratory conditions differ significantly across programs. CDC-reported live birth rates range from under 1% to 44% across all age groups combined within these 582 clinics. This range reflects the clinics' patient populations — not a direct quality ranking. Clinics treating higher proportions of older patients or complex diagnoses — including diminished ovarian reserve and repeated implantation failure — will report lower aggregate rates. Compare clinics exclusively within the same patient age bracket using individual clinic-level CDC NASS profiles.
How Much Does IVF Cost in the United States?
A single IVF cycle costs $12,000–$25,000 for the base procedure — ovarian stimulation monitoring, egg retrieval, fertilization, embryo culture, and embryo transfer — before medications or add-ons. IVF pricing is not federally regulated and varies by clinic, geographic market, and patient-specific protocol. Gonadotropin medications add $3,000–$7,000 per stimulation cycle. 21 US states mandate fertility insurance coverage, with scope varying significantly by state law.
| Base IVF cycle (monitoring + retrieval + lab + transfer) | $12,000–$25,000 |
| Gonadotropin medications (FSH, LH) | $3,000–$7,000 per cycle |
| ICSI (intracytoplasmic sperm injection) | $1,000–$2,500 add-on |
| PGT-A (preimplantation genetic testing for aneuploidy) | $3,000–$6,000 |
| Embryo cryostorage (annual) | $500–$1,000 per year |
| Frozen embryo transfer (FET) | $3,000–$5,000 per transfer |
| Donor egg IVF (fresh or frozen donor cycle) | $25,000–$50,000+ |
| State insurance mandates | 21 US states — IL, NY, NJ, MA, CA + 16 others (scope varies) |
Does Insurance Cover IVF in the United States?
21 US states — including Illinois, New York, New Jersey, Massachusetts, and California — mandate that health insurance plans cover fertility treatments, but coverage scope varies by state law. Illinois and New York mandate coverage for full IVF cycles including egg retrieval and embryo transfer. Other states, such as California, mandate only infertility diagnosis coverage without requiring IVF treatment to be covered. Patients in the remaining 29 non-mandate states pay entirely out-of-pocket or access fertility benefits through employer-sponsored programs — including Progyny and WINFertility — offered by large US employers. Always confirm your plan's specific IVF benefit before beginning a cycle.
Who Is a Candidate for IVF?
IVF is indicated for patients with bilateral tubal factor, severe male-factor infertility, diminished ovarian reserve, endometriosis, or unexplained infertility after 3–6 failed IUI cycles, as defined by ASRM Practice Guidelines. IVF is also the required pathway for patients needing preimplantation genetic testing (PGT-A or PGT-M) and for same-sex male couples or single individuals pursuing gestational surrogacy.
- Bilateral tubal factor — blocked or absent fallopian tubes, including bilateral salpingectomy and hydrosalpinx confirmed by hysterosalpingogram (HSG) or laparoscopy
- Severe male-factor infertility — requiring ICSI for conditions including azoospermia (no sperm in ejaculate), severe oligospermia (total motile count below 1 million), and complete teratospermia
- Unexplained infertility — failure of 3–6 IUI cycles with patent fallopian tubes, normal ovarian reserve, and normal semen analysis
- Advanced maternal age (38+) — where time-sensitive ART intervention is clinically indicated to preserve embryo quantity before further age-related egg quality decline
- Diminished ovarian reserve — antral follicle count below 5 or day-3 FSH above 10 mIU/mL, indicating reduced ovarian response to stimulation
- Endometriosis (stage III–IV) — with pelvic adhesions, ovarian endometriomas, or tubal occlusion confirmed by laparoscopy that impairs natural fertilization
- PGT-A or PGT-M requirement — chromosomal translocation carriers, patients with recurrent aneuploid pregnancy loss, or those with monogenic (single-gene) disease risk requiring embryo biopsy and genetic screening
- Third-party reproduction — same-sex male couples and single individuals requiring a gestational carrier (surrogate) and donor eggs or donor sperm to achieve pregnancy
What Are the Risks of IVF?
The primary clinical risks of IVF are ovarian hyperstimulation syndrome (OHSS), multiple gestation, and egg retrieval complications — including pelvic infection and intraperitoneal bleeding. Modern IVF protocols — particularly the freeze-all strategy and GnRH agonist trigger shots — have significantly reduced severe OHSS rates. The American Society for Reproductive Medicine (ASRM) recommends single embryo transfer (SET) to eliminate the multiple gestation risk in eligible patients.
- Ovarian hyperstimulation syndrome (OHSS) — severe form occurs in 1–2% of stimulated IVF cycles and is characterized by ovarian enlargement, ascites (abdominal fluid accumulation), hemoconcentration, and electrolyte imbalances requiring clinical monitoring or hospitalization
- Multiple gestation — twins or triplets occurs in 20–30% of cycles with multi-embryo transfer and is reduced to under 2% with elective single embryo transfer (eSET) in patients with good-quality blastocysts
- Egg retrieval complications — pelvic infection and intraperitoneal bleeding occur in under 1% of retrievals and are managed with prophylactic antibiotics and post-procedure monitoring for 1–2 hours
- Ectopic pregnancy following embryo transfer occurs in approximately 2–5% of IVF pregnancies — higher than the natural conception rate — and is monitored with serial beta-hCG and early transvaginal ultrasound at 5–6 weeks
- Cycle cancellation due to poor ovarian response (fewer than 3 follicles) or excessive hyperstimulation risk occurs in 5–10% of stimulated cycles and is determined by the treating reproductive endocrinologist based on serial monitoring data
What Is the Difference Between IVF and IUI?
IVF and IUI differ in fertilization location, egg retrieval requirement, live birth rate, cost, invasiveness, embryo genetic testing capability, and federal CDC reporting status. IVF fertilizes eggs outside the body in an embryology laboratory, while IUI places a prepared sperm sample directly into the uterine cavity for fertilization to occur in the fallopian tube. IVF delivers a 49.7% live birth rate per cycle for patients under 35 versus 10–20% per IUI cycle in the peer-reviewed literature.
| Fertilization location | IVF: embryology laboratory (in vitro) | IUI: fallopian tube (in vivo) |
| Egg retrieval | IVF: required — transvaginal aspiration under IV sedation | IUI: not required |
| Live birth rate — under 35 | IVF: 49.7% per cycle (CDC NASS 2022) | IUI: 10–20% per cycle (literature) |
| Cost per cycle | IVF: $12,000–$25,000 base | IUI: $300–$1,500 |
| Invasiveness | IVF: outpatient surgical retrieval under IV sedation | IUI: 5-minute office procedure, no sedation |
| Embryo genetic testing | IVF: PGT-A and PGT-M available on day-5 biopsy | IUI: not available |
| Federal CDC reporting | IVF: mandatory annual reporting via CDC NASS | IUI: not tracked by CDC |
How Long Does IVF Take?
A fresh IVF transfer cycle takes 4–6 weeks from the first day of ovarian stimulation to the serum beta-hCG pregnancy test. A frozen embryo transfer (FET) cycle with PGT-A genetic testing takes 10–14 weeks because embryos are vitrified after biopsy and transferred in a separate, hormonally prepared cycle once genetic results — which take 7–14 days — are received. The full process including initial consultation, baseline bloodwork, and pre-cycle diagnostic testing spans 2–3 months before stimulation begins.
| Initial consultation + baseline workup | 2–4 weeks |
| Ovarian stimulation (gonadotropin injections) | 8–14 days |
| Egg retrieval | 1 day — outpatient procedure, 20–30 minutes |
| Fertilization + embryo culture to blastocyst | 5–6 days |
| PGT-A genetic testing (embryos vitrified while waiting) | 7–14 days |
| FET cycle preparation (estradiol + progesterone) | 3–4 weeks |
| Beta-hCG pregnancy test | 9–11 days post-transfer |
| Total — fresh embryo transfer cycle | 4–6 weeks from stimulation start |
| Total — FET cycle with PGT-A | 10–14 weeks from stimulation start |
Where Can You Find IVF Clinics Near You?
All 582 clinics in this directory perform IVF and report outcomes annually to the CDC NASS under federal law. Browse by city below to compare CDC-verified live birth rates for individual clinics within your specific age bracket — under 35, 35–37, 38–40, 41–42, or over 42.
Browse by state: California · Texas · New York · Florida · Illinois